It’s ASCO weekend, but that doesn’t mean we can’t do a good ol’ Top Ten. From the looks of it, it seems like the Pixantrone/CTIC frenzy is starting to die down a bit. Patrick Swayze continues to be the center of attention and everyone is talking about ASCO.

Ok, here we go — last week’s Top Ten: the stories that made us all laugh, cry, gasp and scream!!!

10 – ASCO Starts Today, Secrets Revealed, Media Going Crazy

9 – More Cell Therapeutics: OPAXIO vs. Pixantrone, The Race is On

8 – Cell Therapeutics Shareholders to Adam Feuerstein: You’re a D@$*!!!

7 – Cell Therapeutics’ Pixantrone: Hype or Truth?

6 – More ASCO Watch, Plus The Street’s Adam Feuerstein Talks ASCO

5 – Genta’s Tesetaxel – Hype or Truth?

4 – Did Vatalanib Work for Patrick Swayze?

3 – An Exhausted Genasense Nears Its End…

2 – ASCO Watch 09: Genta, Exelixis, Roche/Genentech, Cell Therapeutics

And last week’s most viewed post is…

1 – Hamburg’s Husband Top Guy at Renaissance, Must Divest

And there you have it…

Anonymous Tip? Comments? Contact us at: hr@iguanabio.com

Related Posts